M. Kraus & Co boosted its stake in shares of MetLife, Inc. (NYSE:MET) by 1.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 88,038 shares of the financial services provider’s stock after buying an additional 1,611 shares during the period. MetLife accounts for about 3.1% of M. Kraus & Co’s portfolio, making the stock its 16th largest position. M. Kraus & Co’s holdings in MetLife were worth $4,837,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in MET. BlackRock Inc. increased its stake in MetLife by 3,323.3% in the first quarter. BlackRock Inc. now owns 68,475,870 shares of the financial services provider’s stock worth $3,616,895,000 after buying an additional 66,475,603 shares in the last quarter. Vanguard Group Inc. increased its stake in MetLife by 3.0% in the first quarter. Vanguard Group Inc. now owns 65,364,620 shares of the financial services provider’s stock worth $3,452,559,000 after buying an additional 1,885,246 shares in the last quarter. State Street Corp boosted its position in shares of MetLife by 1.4% in the first quarter. State Street Corp now owns 49,020,964 shares of the financial services provider’s stock worth $2,589,297,000 after buying an additional 680,903 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of MetLife by 6.9% in the first quarter. Geode Capital Management LLC now owns 10,265,096 shares of the financial services provider’s stock worth $541,427,000 after buying an additional 664,918 shares during the last quarter. Finally, Morgan Stanley boosted its position in shares of MetLife by 5.4% in the first quarter. Morgan Stanley now owns 7,946,397 shares of the financial services provider’s stock worth $419,728,000 after buying an additional 404,104 shares during the last quarter. 74.83% of the stock is owned by hedge funds and other institutional investors.

MetLife, Inc. (NYSE MET) traded up 0.15% during midday trading on Friday, reaching $46.81. 6,437,764 shares of the company traded hands. MetLife, Inc. has a one year low of $35.64 and a one year high of $51.77. The stock has a market capitalization of $49.75 billion, a P/E ratio of 550.71 and a beta of 1.46. The company has a 50 day moving average price of $48.80 and a 200-day moving average price of $47.31.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $17.39 billion for the quarter, compared to the consensus estimate of $17.11 billion. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The company’s revenue for the quarter was up 2.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.83 EPS. Analysts forecast that MetLife, Inc. will post $4.91 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Monday, August 7th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 3.42%. The ex-dividend date of this dividend is Thursday, August 3rd. MetLife’s dividend payout ratio (DPR) is 1,777.98%.

WARNING: “M. Kraus & Co Has $4.84 Million Position in MetLife, Inc. (NYSE:MET)” was reported by Daily Political and is owned by of Daily Political. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/08/13/m-kraus-co-has-4-84-million-position-in-metlife-inc-nysemet.html.

MET has been the topic of a number of analyst reports. TheStreet cut shares of MetLife from a “b-” rating to a “c” rating in a research report on Tuesday, May 16th. ValuEngine upgraded shares of MetLife from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, June 27th. Citigroup Inc. set a $51.00 target price on shares of MetLife and gave the stock a “sell” rating in a research report on Friday, July 7th. BidaskClub upgraded shares of MetLife from a “strong sell” rating to a “sell” rating in a research report on Saturday, June 10th. Finally, Wells Fargo & Company reiterated a “buy” rating on shares of MetLife in a research report on Thursday, May 4th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $59.17.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.